USPTO serial 99946894
PROGLYCEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- NKOJO, RHODA K
- Law office
- TMO LAW OFFICE 117
What this means
Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.
Need help with PROGLYCEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Colman Ragan
Colman Ragan Teva Pharmaceuticals USA, Inc.400 Interpace ParkwayBuilding AParsippany, NJ 07054Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | hyperglycemic agent | ACTIVE | Aug 1, 1976 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2026 | NWAP | NEW APPLICATION ENTERED | — |